Assessment of YME1L and mitofusin2 as a possible diagnostic and/or therapeutic target in hepatocellular carcinoma. (2023). Indian Journal of Biochemistry and Biophysics (IJBB), 60(1), 43-54. https://doi.org/10.56042/ijbb.v60i1.62503